BamSEC and AlphaSense Join Forces
Learn More

Merrimack Pharmaceuticals Inc

Formerly NASDAQ: MACK
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5(1)
from 10-K 2 pages First Amendment to Section 382 Rights Agreement
12/34/56
EX-4.5
from 10-K 7 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4
from 10-K 2 pages First Amendment to Section 382 Rights Agreement
12/34/56
EX-4
from 10-K 7 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.5
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.5
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.5
from 10-K 5 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.1
from 8-K 52 pages Section 382 Rights Agreement Dated as of December 3, 2019 Between Merrimack Pharmaceuticals, Inc. and Computershare Trust Company, N.A. as Rights Agent
12/34/56
EX-4.1
from 10-K 2 pages Indenture or similar
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3 60 pages Merrimack Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 56 pages Merrimack Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 193 pages Merrimack Pharmaceuticals, Inc., as Issuer, and Any Guarantor That Becomes Party Hereto Pursuant to Section 4.10 Hereof 11.5% Senior Secured Notes Due 2022 Indenture Dated as of December 22, 2015 U.S. Bank National Association, as Trustee and as Collateral Agent
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3 60 pages Merrimack Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities Cross-Refrence Table
12/34/56
EX-4.1
from S-3 55 pages Merrimack Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.2
from 8-K 72 pages Merrimack Pharmaceuticals, Inc. and Wells Fargo Bank, National Association, as Trustee First Supplemental Indenture Dated as of July 17, 2013 4.50% Convertible Senior Notes Due 2020
12/34/56
EX-4.1
from 8-K 57 pages Merrimack Pharmaceuticals, Inc. and Wells Fargo Bank, National Association Trustee Indenture Dated as of July 17, 2013 Senior Debt Securities
12/34/56